Dr. Huang joined Morningside in 2003, and is now in charge of Morningside’s overall healthcare investment activities in China. With more than 16 years’ VC industry experience, Dr. Huang has led nearly 3 dozens healthcare/life-science investments in greater China and the North America, representing Morningside on various company boards. Morningside healthcare/life-science investments cover sectors across bio-pharmaceutical, medical devices, IVD, healthcare services, healthcare IT and etc.

Prior to joining Morningside, Dr. Huang served as a Marketing Associate in the Public Relations & Marketing group at Continuum Health Partners in New York City, which provides integrated healthcare management services throughout the New York metropolitan region.

Dr. Huang holds her medical degree from Shanghai Jiao Tong University Medical School (Former Shanghai Second Medical University), trained and practiced in Obstetrics/Gynecology; and her M.B.A. degree from St. John’s University, New York.